ALS LIMITED (ALQ)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ALQ - ALS LIMITED

FNArena Sector : Industrial Sector Contractors & Engineers
Year End: March
GICS Industry Group : Commercial & Professional Services
Debt/EBITDA: 2.92
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

ALS Ltd provides laboratory and testing services across the mining, industrial and life sciences sector. It operates in over 65 countries. Formerly Campbell Brothers Ltd it first listed in 1952 and changed name to ALS in 2012.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$14.56

22 Jul
2024

0.180

OPEN

$14.55

1.25%

HIGH

$14.78

870,296

LOW

$14.44

TARGET
$14.20 -2.5% downside
Franking for last dividend paid out: 20%
OTHER COMPANIES IN THE SAME SECTOR
AVD . BSA . CG1 . CLG . CVL . CWY . CXL . DOW . DUR . EGN . EVS . FLC . IPG . LBL . MAD . PPK . SDV . SHA . SND . SSM . VEE . VNT .
FNARENA'S MARKET CONSENSUS FORECASTS
ALQ: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx 2.7 66.5 xxx
DPS (cps) xxx 39.2 39.6 xxx
EPS Growth xxx - 95.4% 100.0% xxx
DPS Growth xxx - 1.3% 1.0% xxx
PE Ratio xxx N/A 22.2 xxx
Dividend Yield xxx N/A 2.7% xxx
Div Pay Ratio(%) xxx 1468.2% 59.6% xxx

Dividend yield today if purchased 3 years ago: 3.15%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 2.66

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 12/06 - ex-div 19.6c (franking 20%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx2.7
DPS All xxxxxxxxxxxxxxx39.2
Sales/Revenue xxxxxxxxxxxxxxx2,461.6 M
Book Value Per Share xxxxxxxxxxxxxxx244.4
Net Operating Cash Flow xxxxxxxxxxxxxxx359.2 M
Net Profit Margin xxxxxxxxxxxxxxx0.52 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx1.01 %
Return on Invested Capital xxxxxxxxxxxxxxx0.48 %
Return on Assets xxxxxxxxxxxxxxx0.36 %
Return on Equity xxxxxxxxxxxxxxx1.01 %
Return on Total Capital xxxxxxxxxxxxxxx15.86 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx17.9 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx318 M
Long Term Debt xxxxxxxxxxxxxxx1,554 M
Total Debt xxxxxxxxxxxxxxx1,872 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx300 M
Price To Book Value xxxxxxxxxxxxxxx5.37

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx151.7 M
Capex % of Sales xxxxxxxxxxxxxxx6.16 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,624 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx371 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx46 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.5

No. Of Recommendations

4
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

UBS

xx/xx/xxxx

1

xxxxxxx xx xxx xxxx xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

29/05/2024

1

Add

$15.50

6.46%

While Morgans detected few surprises within ALS Ltd's FY24 results, outlook commentary suggests benefits will flow from a margin recovery in Life Sciences, as well as a cyclical volume recovery in Commodities.

Other supporting factors include gold and copper prices trading at around all-time highs, up by more than 20% compared to average prices in 2023.

Management is aiming for mid-single digit organic growth for the group in FY25 which is consistent with the broker's forecasts.

The Add rating is maintained and the target rises to $15.50 from $15.00.

FORECAST
Morgans forecasts a full year FY25 dividend of 40.00 cents and EPS of 67.40 cents.
Morgans forecasts a full year FY26 dividend of 44.00 cents and EPS of 73.90 cents.

Ord Minnett

xx/xx/xxxx

5

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

xx/xx/xxxx

2

xxxxxxxxx xx xxxxxxxxxx xxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Goldman Sachs

27/05/2024

1

Buy

$15.60

7.14%

Following a review of in-line FY24 results by ALS Ltd, Goldman Sachs, suggests minerals margins are exhibiting resilience through the cycle, and the cycle may be turning.

Within the Life Sciences division, Environmental was steady, while recoveries for Food and Pharma are yet to play out, observe the analysts

Goldman Sachs raises its FY25-27 earnings (EBIT) forecasts by 5%, 7% and 8%, respectively, to partly reflect improvements in the
Pharmaceutical and Food businesses and stronger conviction around Mineral’s margin resilience.

Buy. Target rises by $2.00 to $15.60.

FORECAST
Goldman Sachs forecasts a full year FY25 dividend of 41.00 cents and EPS of 69.00 cents.
Goldman Sachs forecasts a full year FY26 dividend of 45.00 cents and EPS of 75.00 cents.
Access Stockbroker Research History >

ALQ STOCK CHART

FNArena News on ALQ

1
Rudi’s View: Rate Cuts, Growth & Small Caps

Jul 18 2024 - Rudi's View
2
Rudi’s View: Gold, Healthcare, Staples & Copper

Jul 11 2024 - Rudi's View
3
Rudi’s View: Met Coal, Banks, GenAi & Buying-The-Dip

Jul 04 2024 - Rudi's View
4
Next Week At A Glance – 10-14 Jun 2024

Jun 07 2024 - Weekly Reports
5
In Case You Missed It – BC Extra Upgrades & Downgrades – 31-05-24

May 31 2024 - Weekly Reports

Latest Industrial Sector Contractors & Engineers News

1
Ventia Services: Unique Mix Of Growth & Defence

Jul 09 2024 - Small Caps
2
In The Bin; ASX-Listed Waste Companies

Nov 02 2023 - Australia
3
Treasure Chest: ALS Has A Turn-Around Option

Sep 19 2023 - Treasure Chest
4
ESG Focus: Waste To Energy Innovators

Jul 18 2023 - ESG Focus
5
ESG Focus: Waste to Energy Firing Up

Jun 30 2023 - ESG Focus
6
Upgrades Reflect Cost Control at ALS

Mar 31 2023 - Australia
7
Cleanaway: Wait For Cheaper Prices

Oct 11 2022 - Technicals
8
New Age Drives Growth For ALS

Sep 14 2022 - Australia
9
High Growth To Be High Cost For Cleanaway

Jun 15 2022 - Australia
10
New Growth Pathway for Cleanaway Waste Management

Mar 14 2022 - Australia